Your session is about to expire
← Back to Search
Antihistamine
Cromolyn Sodium for Chronic Prostatitis
Phase < 1
Waitlist Available
Led By Praveen Thumbikat, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights
Study Summary
This trial will study if mast cells and the histamine 1 receptor (H1R) can be potential targets for treatment of CP/CPPS.
Eligible Conditions
- Chronic Prostatitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mast cell tryptase levels in expressed prostatic secretions
Secondary outcome measures
AUA-SI score
NIH-CPSI score
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment armExperimental Treatment2 Interventions
Treated arm with cromolyn sodium and cetirizine hydrochloride
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cromoglicic acid
FDA approved
Cetirizine
FDA approved
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,586 Previous Clinical Trials
916,961 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,314,571 Total Patients Enrolled
Praveen Thumbikat, PhDPrincipal Investigator - Northwestern University
Northwestern University
2 Previous Clinical Trials
197 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger